Table 1.
Clinical characteristics of the study population.
| Parameter | n = 212 |
|---|---|
| Age, years | 61 ± 10 |
| Male Gender, n (%) | 146 (68.9) |
| Indication for ablation • Paroxysmal AF, n (%) • Persistent AF, n (%) |
• 130 (61.3) • 82 (38.7) |
| History of atrial flutter/atrial tachycardia, n (%) | 44 (20.8) |
| LVEF, % | 56 ± 10 |
| Cardiomyopathy, n (%) | 55 (25.9) |
| Hypertension, n (%) | 105 (49.5) |
| Coronary artery disease, n (%) | 28 (13.2) |
| History of heart failure, n (%) | 36 (17.0) |
| COPD, n (%) | 9 (4.2) |
| CKD, n (%) | 12 (5.7) |
| ACE-ARB, n (%) | 79 (37.3) |
| Beta-blockers, n (%) | 124 (59.0) |
| Antiarrhythmics, n (%) | 144 (67.9) |
| Procedure duration, min | 115 ± 41 |
| Fluoroscopy time, min | 10.3 ± 7 |
| RF applications, n | 68 ± 23 |
| RF duration time, s | 9.2 ± 4 |
| Mean Power, W | 48 ± 2 |
| Complications during the procedure, n (%) | 0 (0) |
| Minor complications • Vascular complications • Pericarditis |
7 (3.3) • 4 • 3 |